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During maternal recognition of pregnancy (MRP), a conceptus-derived signal leads to the persistence 
of the corpus luteum and the maintenance of gestation. In the horse, the nature of this signal remains 
to be elucidated. Several studies have focused on the changes in gene expression during MRP, but little 
information exists at the protein level. The aim of this study was to identify the proteins at the embryo-
maternal interface around signalling of MRP in the horse (day 13) by means of mass spectrometry. 
A distinct influence of pregnancy was established, with 119 proteins differentially expressed in the 
uterine fluid of pregnant mares compared to cyclic mares and with upregulation of several inhibitors of 
the prostaglandin synthesis during pregnancy. By creating an overview of the proteins at the embryo-
maternal interface in the horse, this study provides a solid foundation for further targeted studies of 
proteins potentially involved in embryo-maternal interactions, MRP and pregnancy loss in the horse.
Maternal recognition of pregnancy (MRP) covers the series of events leading to the persistence of the corpus 
luteum and a receptive uterine environment to support the maintenance of gestation1. In the cycling mare, pul-
satile release of prostaglandin F2α (PGF2α) causes luteolysis, resulting in a decline in progesterone. This mecha-
nism is inhibited during pregnancy by the presence of the conceptus2. In pigs, the conceptus derived signal which 
initiates MRP has been identified a long time ago as oestrogen3 and in ruminants as interferon tau4,5. However, 
the nature of this signal remains to be elucidated in the horse despite several decades of elaborate research on 
this topic6,7. Initial studies have focused on the identity of specific candidate signalling molecules and while the 
equine embryo produces substantial quantities of oestrogen as well as prostaglandins (PG) and limited amounts 
of interferons, no convincing evidence exists for their signalling role in MRP7. Potential embryonic signal tar-
gets involved in the luteostatic mechanism in the horse are prostaglandin-endoperoxide synthase 2 (PTGS2), an 
enzyme in the biosynthesis of PGF2α, and oxytocin, which stimulates endometrial PGF2α secretion through a 
positive feedback loop8. Both PTGS2 and oxytocin receptor expression (OXTR) are repressed during early preg-
nancy compared to cycling mares, with downregulation of PTGS2 at the RNA level and of OXTR at the protein 
level9–13.
During the last years, the topic of MRP in the horse has been broadened to all pathways involved in 
embryo-maternal communication around the timing of MRP. Signalling of MRP is a continuum of events, esti-
mated to occur between days 12 and 14. Recipient mares can still get pregnant when an embryo is transferred 
to their uterus at day 12, but not at day 14 after ovulation14, while repression of PTGS2 occurs by day 13 of 
pregnancy11. By day 16, clear differences between pregnant and cyclic horses are observed. Transcriptomics of 
the equine endometrium and equine conceptuses have substantially contributed to the knowledge on pathways 
affected around the timing of MRP in the horse7,15–19. Technological advantages, including sequencing, favoured 
development of genomics and transcriptomics compared to proteomics20. However, mRNA abundances can only 
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explain 40% of the variation in protein levels and the actual protein profile is influenced by post-transcriptional 
regulation mechanisms21. This appeals for complementing transcriptomics knowledge on MRP with quantitative 
proteomics. This can now be achieved through mass spectrometry (MS). Recent improvements in MS technolo-
gies, including data-independent-acquisition, allow reproducible label-free quantification of proteins in complex 
biological samples22.
Mass spectrometry of the embryo-maternal interface around MRP has been performed in several farm ani-
mals including pigs23,24, sheep25 and cattle26–28. In the horse, specific molecules with a potential role in MRP have 
been targeted by immunohistochemistry13,29–32 and global screening of uterine proteins has been performed in 
the context of endometritis33. However, the effect of pregnancy on the uterine secretome has not been assessed by 
means of high-throughput proteomics in the horse up to now. In a recent study, equine blastocysts were collected 
by uterine lavage on day 8 and an MS analysis was performed of the proteins secreted during culture of these 
embryos for 24 h and 48 h and of proteins present in the blastocoel fluid and the embryo capsule34. The authors 
detected prostaglandin F2 receptor inhibitor (PTGFRN) and a progesterone potentiating protein, FK506 binding 
protein 4 (FKBP4), in the blastocoel fluid, but it remained to be determined whether these proteins were actively 
secreted into the uterine lumen.
The aim of this study was to gain new insights into the embryo-maternal communication around the signal-
ling of MRP in the horse. Since signalling of MRP is estimated to occur between Day 12 and Day 14, sampling 
was performed at Day 13 (±0.5 day). We hypothesize that high-throughput proteomics can provide complemen-
tary information to the transcriptomic reports. To this end, proteomics was performed by high definition data 
independent mass spectrometry (HDMSE) with ion mobility drift time-specific collision-energy35. In this way, 
proteins were identified and quantified in uterine fluid of pregnant and cyclic mares as well in the yolk sac fluid 
of the pregnant mares.
Results
Sampling. Only reproductively sound mares with negative bacteriology and cytology of the uterine fluid were 
used for the sampling. In two cycles, namely one pregnant (P) and one control cyclic (C) cycle, a double ovulation 
occurred. Response to hCG resulted in ovulation 24–36 h after administration. In four cycles, ovulation only 
occurred 3 days after hCG; once in a P cycle, where artificial insemination (AI) was performed at the same time 
and in this case, the mare was inseminated a second time 48 h after the first time and she ovulated the day after. In 
all other P cycles, ovulation occurred within 48 h after AI. In one mare, a line of fluid was noticed by ultrasound 
of the uterus 1 day after AI and she was treated by intramuscular administration of oxytocin.
Identification of proteins. The average protein concentration was similar in the uterine fluid (UF) of P 
(9.2 g/mL) and C (9.8 g/mL) mares, while the average protein concentration in the yolk sac (YS) was only 78 µg/mL.
For the first time, an overview was created of the proteins present in the UF and the YS at day 13 after ovula-
tion in the horse. In the UF samples, a total of 10489 peptides were identified, accounting for 41% of all peptide 
like ions. Protein identification resulted in 1153 identifiable proteins (Supplementary file 1). After filtering and 
normalization, a total of 707 normalized proteins with at least two unique peptides were assessed for differential 
expression.
Differential expression of proteins was assessed for P versus C mares and pregnancy was associated with 
upregulation of 62 proteins (Table 1) and downregulation of 57 proteins (Table 2). For all proteins in this com-
parison, the log fold change, the adjusted p-value and the number of peptides are listed in Supplementary file 3.
In the YS samples, a total of 6500 peptide ions were identified, representing 51% of all peptide like ions and 
resulting in 903 identifiable proteins (Supplementary file 2). For the YS proteins, the primary goal was identifica-
tion, rather than quantification, as different nature of the fluids impedes assessment of differential expression of 
proteins in YS versus UF.
Gene Ontology enrichment and pathway analysis. Categorization in the Gene Ontology (GO) terms 
‘molecular function’, ‘biological process’ and ‘cellular component’ is provided for all quantified proteins in the 
comparison of P versus C in Supplementary file 3.
Figure 1 summarizes the GO categories in which the differentially expressed proteins are involved. The main 
category to which most proteins are assigned is ‘cellular process (GO:0009987)’ for the biological processes and 
‘binding (GO:0005488)’ for the molecular functions. This coincides with the results in porcine uterine fluid24, but 
these are also the major categories when all proteins are taken into account. Overall, the differences in categori-
zation between the groups are small.
Gene Ontology (GO) enrichment revealed no statistical overrepresentation when a Bonferroni correction 
for multiple testing was used (FDR < 0.05). No up- or downregulated KEGG pathways were detected either at a 
Benjamini-Hochberg corrected p-value of 0.05.
Embryo-maternal interaction. Comparison of the proteins identified in the UF of the P mares and in the 
YS of the corresponding embryo revealed 347 common proteins, 806 proteins which were only detected in the UF 
and 556 proteins which were only found in the YS. Figure 2 represents an overview of these UF specific proteins, 
YS specific proteins and common proteins, with specific display of the proteins up- and downregulated during 
pregnancy and of the proteins categorized in the extracellular space.
A list of the 347 common proteins is provided in Supplementary file 4, including the functions in which these 
proteins are involved. Figure 3 summarizes the GOs in which these common proteins were involved. Similar to 
the results for the UF in Fig. 1, the main GO categories in which the common proteins are involved are also ‘cel-
lular process (GO:0009987)’ and ‘binding (GO:0005488)’ and differences in categorization are small. Common 
proteins in YS and UF which were also upregulated in P versus C, showed a higher representation in the biological 
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Protein Symbol Log FC Adj. p-value Gene Symbol Gene Description
F7BAA0 2,27 0,03617 GSTO1* glutathione S-transferase omega 1
F6Z0A9 2,02 0,01980 RAC1* ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
F6VVU1; F6YMX5 1,96 0,02370 MOB1A* MOB kinase activator 1A
F6Y2H3; F6Y2V7 1,89 0,02907 PEPD* peptidase D
F7CCF5 1,81 0,01425 LXN* latexin
F7DIB3 1,80 0,03253 SEC14L3* SEC14 like lipid binding 3
F6YAZ9; F7BYZ9 1,79 0,01633 MYL12A* myosin light chain 12A
F6RH25 1,55 0,01371 DCPS* decapping enzyme, scavenger
F6XV30 1,55 0,01980 TBCA* tubulin folding cofactor A
Q3S4D6 1,53 0,01915 GM2A GM2 ganglioside activator
F6XKI9 1,40 0,01142 DNTTIP2* deoxynucleotidyltransferase terminal interacting protein 2
F6RTH0 1,39 0,01378 TXNDC17* thioredoxin domain containing 17
F7CBN0 1,35 0,00336 AKR1A1 aldo-keto reductase family 1 member A1
F6PWC8 1,25 0,00112 PTGR1* prostaglandin reductase 1
F6XSN2 1,24 0,00106 CCT7* chaperonin containing TCP1 subunit 7
F6XZQ1 1,24 0,00026 CAPS* calcyphosine
F7BAR2 1,23 0,02275 TPMT Thiopurine S-methyltransferase
F6W8C8 1,20 0,00004 SERPINB6* serpin family B member 6
F6RGN2 1,19 0,04597 FABP5* fatty acid binding protein 5
F6RMM1 1,17 0,00336 SH3BGRL SH3 domain binding glutamate rich protein like
F7CBR0; F7DZD2 1,11 0,00336 LOC100050322 Glutathione S-transferase
F7BHV8 1,11 0,00626 TUBB4A* tubulin beta 4A class IVa
Q8HZM6; F7A0T0 1,09 0,00106 ANXA1 Annexin A1
F6XA04 1,06 0,00001 YWHAE* tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon
F6XTY8 1,05 0,02235 Unassigned unassigned
F7D3E3 1,03 0,00004 CMPK1* cytidine/uridine monophosphate kinase 1
F6W683 0,99 0,03617 GMDS* GDP-mannose 4,6-dehydratase
F7DB59 0,99 0,00106 PAFAH1B3* platelet activating factor acetylhydrolase 1b catalytic subunit 3
F6SQ49 0,97 0,00112 SMS* spermine synthase
F6RL46 0,96 0,01211 PGLS* 6-phosphogluconolactonase
F6W9B1 0,93 0,01371 ST13 suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein)
F7E0H3 0,91 0,01211 TUBB* tubulin beta class I
F6R8T8 0,90 0,01473 ACY1 aminoacylase 1
F7D9J2 0,90 0,00053 TKT* transketolase
F6W039 0,85 0,00024 ARHGDIA* Rho GDP dissociation inhibitor alpha
F6ZHQ5 0,83 0,00336 CLIC1 chloride intracellular channel 1
F7D1R1 0,82 0,01371 PGK1 Phosphoglycerate kinase 1
F6TZS9 0,77 0,01633 TPI1 triosephosphate isomerase 1
F7CIX6 0,76 0,00591 ENO2* enolase 2
F6W3T1 0,73 0,00106 LDHA lactate dehydrogenase A
F7C5G3 0,73 0,01378 PSMD11* proteasome 26S subunit, non-ATPase 11
F6ZE54 0,72 0,04589 GPI glucose-6-phosphate isomerase
F7BWW6 0,71 0,02824 VCP* valosin containing protein
F7CZS6 0,71 0,01052 MDH1 malate dehydrogenase 1
F6PJY2 0,71 0,04256 LZTFL1* leucine zipper transcription factor like 1
F7DMY1 0,70 0,04029 CBFB* core-binding factor beta subunit
F6UJ33 0,69 0,02943 PFN1 profilin
F6VSN2 0,69 0,00056 GSTP1* glutathione S-transferase pi 1
F7DXG8 0,69 0,01915 CFL1* cofilin 1
F7APS1; F6ZWS7 0,68 0,00106 CSTB; LOC100050835* Cystatin B
F7BE95; F6U2P8 0,67 0,03059 UBE2V1* ubiquitin conjugating enzyme E2 V1
F7ALV0 0,67 0,00336 TXN Thioredoxin
F7BPT4 0,61 0,00336 EZR* Ezrin
Continued
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processes ‘developmental process (GO:0032502)’ and ‘response to stimulus (GO:0050896)’. Molecular functions 
in which these proteins were more involved are ‘transporter activity (GO:0005215)’ and ‘transcription factor 
activity - protein binding (GO:0000988)’, while the common proteins which were downregulated in P versus C 
were rather represented in ‘structural molecule activity (GO:0005198)’.
The embryo-maternal interaction was further visualized by Cytoscape 3.3.0 in Fig. 4. The most prominent GO 
terms in this network are ‘embryo development’ (GO:0009790) and ‘embryo morphogenesis’ (GO:0048598), with 
a main contribution of proteins originating from the yolk sac, and embryo implantation (GO:0007566) with the 
involvement of both uterine and embryonic proteins. In Fig. 5, the contribution of growth factors and cytokines 
in equine embryo-maternal signalling is visualized. The most extensive networks with various proteins found 
in the yolk sac fluid and/or the uterine fluid of pregnant mares are involved in ‘regulation of cytokine produc-
tion’ (GO:0001817), ‘response to cytokine’ (GO:0034097) and the downstream GO’s ‘cytokine receptor binding‘ 
(GO:0005126), ‘cytokine mediated signalling pathway’ (GO:0019221) and ‘regulation of response to cytokine 
stimulus’ (GO:0060759).
Discussion
Maternal recognition of pregnancy is an intriguing subject in the horse and extensive research on the molecular 
processes involved has been performed in the field of transcriptomics7,18. However, information on the down-
stream translation to proteins is scarce. In this study, quantitative proteomics of the uterine luminal fluid assessing 
the effect of pregnancy was performed for the first time in the horse. At the same time, proteins in the embryonic 
yolk sac fluid were mapped to provide insight into the embryo-maternal interaction.
With 119 proteins differentially expressed in the uterine fluid of P versus C mares, a distinct influence of 
pregnancy was established. In general, a function of more than 40% of the differentially expressed proteins in the 
UF was categorized as ‘binding (GO:0005488)’, coinciding with the findings in pigs and cattle, where the majority 
of proteins were also allocated to molecular binding24,28 (Fig. 1). ‘Binding’ also represents the main category to 
which the common proteins in UF and YS were allocated, with subtly higher representation of proteins upreg-
ulated during pregnancy in categories linked to embryo-maternal interaction, namely ‘developmental process 
(GO:0032502)’, ‘response to stimulus (GO:0050896)’, ‘transporter activity (GO:0005215)’ and ‘transcription factor 
activity - protein binding (GO:0000988)’ at the expense of the more general GO term ‘structural molecule activity 
(GO:0005198)’ (Fig. 3). Cellular component categorization allocated 45% of the identified UF proteins to the 
extracellular space (Fig. 2). This coincides with the findings of Swegen et al.34, who specifically targeted secreted 
proteins by analysing embryo-conditioned medium. This supports the fact the proteins detected in our study 
mainly represent the proteins secreted in the uterine fluid rather than endometrial cells shed in the uterine lumen. 
This also accounts for the proteins which were found to be differentially expressed during pregnancy. Sixty four % 
of these proteins were categorized in the extracellular space; the other may have originated from occasional shed-
ding of embryonic and endometrial cells into the uterine lumen. Figure 2 represents an overview of all UF spe-
cific, YS specific and common proteins, including their differential expression in P vs C and their allocation to the 
extracellular space. Interestingly, the majority of proteins commonly found in UF and YS are indeed present in the 
extracellular space. These represent candidate proteins involved in embryo-maternal interaction and signalling. 
In general, our results greatly coincided with the findings of Swegen et al.34 who worked with day 8 blastocysts to 
examine proteins present in and secreted by early equine embryos. Figure 6 shows the number of proteins which 
were commonly found in the blastocoel fluid and the YS and those found to be secreted in embryo-conditioned 
medium at 24 h and 48 h and in the UF in our study. More than two third of the proteins reported in the blasto-
coel fluid were also detected in the YS and more than one third of the proteins found to be secreted after 48 h of 
embryo culture were also detected in the UF. Overlap of the results validates our independent findings on the one 
hand and indicates conserved expression of several proteins throughout development on the other hand.
In the context of MRP, prostaglandin synthesis is of special interest. For three proteins involved in this path-
way, namely prostaglandin reductase 1 (PTGR1), glutathione transferase 1 (GSTP1) and annexin A1 (ANXA1), 
significantly higher amounts were detected in the uterine fluid of pregnant mares compared with cyclic 
mares. Apart from acting on 15-oxo-PGE1, 15-oxo-PGE2 and 15-oxo-PGE2-alpha as 15-oxo-prostaglandin 
13-reductase, PTGR1 catalyzes leukotriene B4 into its biologically less active metabolite, being the key step in the 
metabolic inactivation of leukotriene B4, as depicted in Fig. 7.
Protein Symbol Log FC Adj. p-value Gene Symbol Gene Description
F6S5E7 0,59 0,01211 TARS* threonyl-tRNA synthetase
F6QXW2 0,58 0,01378 PEBP1* phosphatidylethanolamine binding protein 1
F6XLG0; F7DY67 0,57 0,04597 PNP; LOC100058767 Purine nucleoside phosphorylase
F7DZV9 0,57 0,00961 YWHAB* tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta
F7CI32; F7ASU6; 
F7DKR3 0,51 0,03433 SELENBP1* selenium binding protein 1
F7B5P1 0,49 0,03253 CNDP2* CNDP dipeptidase 2 (metallopeptidase M20 family)
F6YZ13 0,48 0,03604 S100A13* S100 calcium binding protein A13
F6ZEV8 0,46 0,01618 DBI* diazepam binding inhibitor, acyl-CoA binding protein
F6X6A6; F6XKX6; 
F6Z5Z4 0,45 0,00423 LOC100052020; LOC100054282 Peptidyl-prolyl cis-trans isomerase
Table 1. Upregulated proteins in the uterine fluid of pregnant versus cyclic mares on day 13 after ovulation.
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Protein ID Log FC adj. P-Value Gene Symbol Gene Description
F6USV6 −0,44 0,04220 NOL11* nucleolar protein 11
F7BF31 −0,52 0,01207 SPI2* alpha-1-antitrypsin
F6WZW6 −0,57 0,01980 PSMA1 proteasome subunit alpha 1
F6YLA3 −0,62 0,00626 TXNRD1* thioredoxin reductase 1
F6YVT0 −0,71 0,01004 RASGRP4* RAS guanyl releasing protein 4
F6ZFH9 −0,72 0,02902 YWHAG* tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma
F7AED2 −0,72 0,01528 LOC100050100* alpha-1-acid glycoprotein 2-like
F7CZW9 −0,73 0,02003 SERPING1* serpin family G member 1
F6T7X3 −0,75 0,00626 LOC100065767 membrane primary amine oxidase
F6RRV1 −0,76 0,00368 FETUB* fetuin B
F7BKK5 −0,76 0,04705 GSTM3* glutathione S-transferase mu 3
F6PQ46 −0,78 0,01052 CP* ceruloplasmin
F6R942; F6RI47 −0,79 0,00336 A2M* Alpha-2-macroglobulin
F6SJ41 −0,82 0,03640 PFN2 profilin 2
F6XWM5 −0,82 0,00041 HP* haptoglobin
F6RMD0 −0,87 0,00516 CFB* complement factor B
F6ZD04 −0,89 0,01443 PYGB glycogen phosphorylase B
P69905 −0,89 0,01010 HBA1 hemoglobin subunit alpha 1
F7AJP3 −0,90 0,02643 CHI3L1* chitinase 3 like 1
F6VTZ7 −0,91 0,00072 CFAP58* cilia and flagella associated protein 58
F6RDD3; F6VE37 −0,91 0,00072 HBB hemoglobin subunit beta
F7BFJ1 −0,92 0,01242 F2 coagulation factor II, thrombin
F6RZ27 −0,93 0,00336 APOA4* apolipoprotein A4
F6WMT7; F7C7Y1 −0,93 0,00053 KRT71; KRT73* keratin 71; keratin 73
F6QS41; F7BQS9 −0,95 0,00336 MROH2A* maestro heat like repeat family member 2A
F6Z2L5 −0,96 0,00005 APOA1* apolipoprotein A1
F6XM13 −0,98 0,01371 APOD* apolipoprotein D
F6XLB1 −0,99 0,00056 LTF Lactotransferrin
F6XRU1; F6YAV2 −1,01 0,00217 SERPINB11* serpin family B member 11
F7DTV1 −1,04 0,01115 PON1* paraoxonase 1
F6SGV0 −1,07 0,00338 TTF2* transcription termination factor 2
Q29482 −1,07 0,01298 CLU clusterin
F6SRP7 −1,10 0,01010 CAP1 adenylate cyclase associated protein 1
F6QX36 −1,13 0,00119 ITIH1* inter-alpha-trypsin inhibitor heavy chain 1
F6TJX5 −1,16 0,03059 TPP1* tripeptidyl peptidase 1
F7BZ41 −1,19 0,02235 CTSL* cathepsin L
F7BNQ2 −1,20 0,00217 C4BPA* complement component 4 binding protein alpha
F7AMJ7 −1,20 0,02095 STK38* serine/threonine kinase 38
F6RM73 −1,22 0,00366 APOA2 Apolipoprotein A-II
F6YNT8 −1,27 0,02370 PEBP4* phosphatidylethanolamine binding protein 4
F6VUW2 −1,30 0,00626 CTSS* cathepsin S
F6TE92 −1,33 0,02043 AGL amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase
F7C0E6 −1,36 0,00259 PLS1* plastin 1
F6X5J6 −1,36 0,02043 ADSL adenylosuccinate lyase
F7BCH1 −1,37 0,00000 INHBA Inhibin beta A chain
F6PUX2 −1,41 0,00026 MSN* moesin
F7DXH4 −1,44 0,00106 VIPAS39* VPS33B interacting protein, apical-basolateral polarity regulator, spe-39 homolog
P01008 −1,54 0,00178 SERPINC1 serpin family C member 1
F7CWC8 −1,57 0,00119 unassigned Amine oxidase [flavin-containing]
F7CWT0 −1,58 0,00056 P19* P19 lipocalin
F6WRK2 −1,59 0,00199 MANBA* mannosidase beta
F7BLE3 −1,69 0,01851 unassigned unassigned
F6QYS3 −1,75 0,01765 ECM1* extracellular matrix protein 1
F6R8P9; F6RM27 −2,13 0,00112 TTLL7* tubulin tyrosine ligase like 7
F6SJN4 −2,22 0,00556 UBOX5* U-box domain containing 5
F7CHR8 −2,23 0,01530 CCDC36* coiled-coil domain containing 36
F6VST0; F6W6H2 −3,34 0,00004 NEFL* neurofilament, light polypeptide
Table 2. Downregulated proteins in the uterine fluid of pregnant versus cyclic mares on day 13 after ovulation.
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While glutathione transferases are also generally involved in the biosynthesis of prostaglandins and leukot-
rienes, as well as progesterone and testosterone36, a specific anti-inflammatory effect of GSTP1 by reduction of 
PTGS2, formerly known as cyclooxygenase-2 (COX-2), has been described37. Furthermore, transport of GSTP1 
across the plasma membrane was demonstrated37. Based upon these observations with recombinant human 
GSTP1 in mice and the high homology of equine GSTP1 with other species, equine GSTP1 in uterine fluid might 
cross the plasma membrane and target intracellular PTGS2. Interestingly, GSTP1 was also detected in the YS of 
the equine conceptuses. In this regard, the pregnancy associated upregulation of GSTP1 observed in the equine 
uterine fluid could be involved in the luteostatic mechanism by inhibiting PTGS2. Further research is needed to 
examine this hypothesis, as this is the first report on the presence of GSTP1 in equine uterine fluid.
Another anti-inflammatory factor with an inhibitory effect on prostaglandin synthesis, more specifically on 
phospholipase A2, is annexin A1 (ANXA1)38,39. Annexin A1 was upregulated in the uterine fluid of the preg-
nant mares when compared to the cyclic mares and this association of annexins with pregnancy coincides with 
literature. An increase in ANXA1 was also reported in the uterine luminal fluid of pregnant ewes from day 10 to 
day 1225. Several annexins have been linked to embryo-maternal interaction. Annexin 4 (ANXA4) was found to 
increase over time from day 10 to day 13 in both cyclic and pregnant pigs24, and we previously reported greater 
quantities of ANXA4 in the oviductal fluid of pregnant mares, when compared to cyclic mares40. In our study, we 
detected annexin 1, 2, 3, 4, 5, 7 8 and 11 in the UF, while ANXA2 and ANXA5 were also found in the YS. Swegen 
et al.34 also reported the presence of ANXA2 in both the equine blastocoel fluid and the embryo-conditioned 
medium after 48 h. The only annexin found to be upregulated during pregnancy was ANXA1. Annexin 1 is an 
inhibitor of phospholipase A2, a rate-limiting enzyme which liberates arachidonic acid for the synthesis of pros-
taglandins and for which a lower enzyme activity of phospholipase A2 has been demonstrated in pregnant mares 
Figure 1. Categorization in Gene Ontology terms of all identified proteins in the uterine fluid (UF) and of 
differentially expressed (DE) proteins in the uterine fluid of pregnant (P) versus cyclic (C) mares. The main 
GO biological processes (a,b), molecular functions (c,d) and structural components (e,f) are represented for all 
quantified proteins in the equine uterine fluid (a,c,e) as well as for proteins found to be differentially expressed 
in the uterine fluid of pregnant versus cyclic mares (b,d,f).
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compared to cyclic mares on day 1441. In our study, phospholipase A2 group IIA (PLA2G2A) tended to be down-
regulated in the uterine fluid of pregnant mares with a logFC of −1.31 compared to the cyclic condition, but it 
was not significant at a 0.05 FDR. Both PLA2G2A and phospholipase A2 group VII (PLA2G7) were detected in 
the YS; the latter was also found in the equine embryo-conditioned medium after 48 h34. Overall, our data suggest 
pregnancy associated interference with the luteolytic eicosanoid pathway with upregulation of inhibitory factors 
at different levels of the prostaglandin synthesis pathway.
A close interaction between prostaglandins and oxytocin has been described in the context of MRP in the 
horse with downregulation of the oxytocin receptor protein in the pregnant endometrium on day 1413. In the pres-
ent study, the presence of oxytocin in the uterine luminal fluid was examined, but it was not detected. However, 
this does not mean it was not present in the original samples; the collection method might have retained some 
peptides and missing values are intrinsic to mass spectrometry42,43. Phosphoinositide phospholipase C (PLCD1), 
involved in the oxytocin receptor signalling pathway, was detected, but not significantly affected by pregnancy44. 
The reduced expression of OXTR during pregnancy has been hypothesized to be induced by an observed decrease 
in the gene expression of oestrogen receptor 1 (ESR1) in the pregnant equine endometrium15. Several proteins 
related to ESR1 were also found to be affected in the uterine fluid. Surprisingly, pregnant mares showed a strong 
upregulation of deoxynucleotidyltransferase terminal interacting protein 2 (DNTTIP2), previously known as oes-
trogen receptor binding protein (ERBP). Binding of DNTTIP2 to ESR1 enhances its transcription45. Upregulation 
of DNTTIP2, which would lead to increased transcription of ESR1 in pregnant mares is contradictory to findings 
in literature and further targeted research is required to clarify this aspect. Downstream of the ESR1, the influence 
of oestrogen on the ezrin–radixin–moesin (ERM) family of actin-binding proteins has been studied, mainly in 
the context of breast cancer46,47. The distribution pattern of ERM-proteins in the blastocyst and the uterus has 
been linked to the implantation potential in mice. Protein analysis of uterine fluid has demonstrated the presence 
of ezrin (EZR) and moesin (MSN) in cattle26,27 and pigs23. In the horse, upregulation of EZR and downregulation 
of MSN was detected, while an inverse association with pregnancy was noted in cattle26,27. We detected both EZR 
and MSN in the YS and they were also found in the blastocoel fluid34.
Apart from the specific interest in proteins involved in prostaglandin synthesis, we also aimed to create a 
general overview of the proteins present at the embryo-maternal interface and potentially involved in signalling. 
Supplementary File 4 presents all proteins which were commonly found in the UF of P mares and in the YS and 
the functions of each protein are included. To visualize their role in embryo-maternal interaction and signalling, 
the proteins involved in GO terms including ‘embryo’, ‘maternal’ or ‘uterus’ are depicted in Fig. 4 and those linked 
to GO terms ‘growth factor’ and ‘cytokine’ in Fig. 5. The origin of the proteins can be distinguished in red (UF), 
yellow (YS) and pink (UF and YS) and up- and downregulation during pregnancy is represented by enlargement 
or shrinkage of the protein respectively. Interestingly, most proteins which were found to be upregulated during 
pregnancy were detected both in UF and in YS, while downregulation during pregnancy generally coincided with 
absence of these proteins in the YS, indicating a potentially important role of the embryo in the production of 
these proteins during pregnancy. Several common proteins were found at the embryo-maternal interface during 
MRP in cattle, including aconitase 1 (ACO1), which was specifically detected in the uterine fluid of pregnant and 
not in cyclic heifers, as well as glucose-6-phospate isomerase (GPI), which has been detected in the uterine fluid 
of both pregnant and cyclic heifers and for which an embryonic source has been presumed based on transcrip-
tomics27. In our study, both proteins were found in the YS and the UF of P mares, with significant upregulation of 
GPI in P versus C. Two other proteins which were commonly found in UF and YS, namely FK506 binding protein 
4 (FKBP4) (Fig. 4) and heat shock protein 90 (HSP90AB1) (Fig. 5), have been elaborately discussed by Swegen et 
al.34 concerning their progesterone supportive role. Co-operation of both factors is necessary for activation of the 
progesterone receptor48, FKBP4 has shown to be crucial for uterine receptivity and implantation in mice49 and 
FKBP4 deficit has been associated with pregnancy loss in human50. While FKBP4 was detected in equine blasto-
coel fluid and speculated to be involved in signalling, it was not detected in the embryo-conditioned medium34. 
Interestingly, we did find both FKBP4 and HSP90AB1, not only in YS, but also in UF, even though their presence 
Figure 2. Proteins identified in the uterine fluid and the yolk sac fluid. The number of common proteins as well 
as the number of proteins specific for the uterine fluid or the yolk sac fluid are displayed. The proteins which 
were found to be upregulated or downregulated in the uterine fluid of pregnant mares compared to cyclic mares 
are depicted separately. Proteins categorized in the extracellular space are also indicated.
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was not affected by pregnancy. While further confirmation of the role of specific proteins is required, the overview 
created in this study can be used as a basis for further targeted studies in the horse.
In addition to the role in prostaglandin and progesterone metabolism, involvement in proteolysis and lipid 
metabolism was also prominent in the commonly detected proteins in our study and the one of Swegen et al.34, 
also coinciding with previous findings on transcriptomics around MRP15. Several cathepsins (G, D, L and S) 
were detected in the UF with downregulation of cathepsin L (CTSL) and S during pregnancy. Pregnancy asso-
ciated downregulation of CTSL1 was also found at the transcriptome level15. Considering lipid metabolism, we 
detected differential expression of lipocalin (P19), apolipoprotein A1 (APOA1) and apolipoprotein D (APOD). 
These proteins are important transporters of essential lipids to the developing conceptus. Retinol binding protein 
(RBP), which also belongs to the lipocalin family, and APOA1 have been detected in uterine fluid of pregnant 
and cyclic pigs, cattle and sheep23–25,27,28, with increasing amounts between day 10 and day 13 in both pregnant 
and cyclic pigs24. In the horse, lipocalin (P19), apolipoprotein A1 (APOA1) and apolipoprotein D (APOD) were 
all downregulated in the uterine fluid of the pregnant mares. Pregnancy associated upregulation of APOA1 was 
reported at the transcriptome level15 and presence of P19 and APOA1 in the yolk sac fluid illustrates their role in 
the embryo-maternal dialogue. Therefore, lower amounts in the uterine fluid during pregnancy rather indicate 
the transport and binding to the conceptus. Lipocalin P19 or uterocalin is a progesterone induced protein, which 
is abundantly present in the equine uterine secretions during dioestrus and early pregnancy51,52. While the early 
developing equine conceptus moves around the uterus, it entirely depends upon the uterine secretions for its 
nutrition and P19 can function as a carrier for essential lipids and amino acids53. Coinciding with our findings, 
P19 has been detected in the trophoblast and the yolk sac fluid of the equine embryo51,52 and it is one of the most 
abundant proteins in the embryonic capsule54–56. Therefore, the lower amount of P19 in P versus C is probably due 
to binding of substantial quantities to the embryo.
While a novel and informative overview is created, it has to be borne in mind that no statistically significant 
results were obtained at the level of molecular functions, biological processes and pathways. Differential expres-
sion of individual proteins was observed between the different UF conditions, and these proteins were categorized 
in GO terms, but statistical analysis showed no significant overrepresentation of any of the GO terms or KEGG 
pathways. Furthermore, it should be noted that MS intrinsically suffers from missing values and conclusions 
based on the absence of proteins cannot be made42,43. However, the field of proteomics has greatly evolved in 
recent years, providing the possibility for statistically robust quantitative comparison of individual protein levels 
in complex biological samples, like uterine fluid22. HDMSE specifically has been shown to provide good proteome 
coverage and reproducibility35. At the same time, however, analysis of GO terms and pathways for proteomics 
is still in its infancy57,58. As many of the here described bioinformatics approaches for proteomic analysis were 
originally developed for genomics, a similar but more matured field, their performance can be expected to show a 
similar growth as that of the genomic approaches. Moreover, the similarity between these fields potentially allows 
an integrated approach in which results from several omics studies can be combined.
Figure 3. Categorization in Gene Ontology terms of common proteins in the uterine fluid of pregnant mares 
(PUF) and the yolk sac fluid (PYS) of the corresponding embryos. The main GO biological processes (a–c) and 
molecular functions (d–f) are represented for all common proteins in equine uterine fluid and yolk sac fluid 
(a,d), as well as for the subset of common proteins which were found to be upregulated (b,e) or downregulated 
(c,f) in the uterine fluid of pregnant mares compared to cyclic mares.
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In conclusion, proteins present in the equine uterine and embryonic yolk sac fluid around the signalling of 
MRP at day 13 were identified and quantified at large scale for the first time in the horse. We detected upregula-
tion of several inhibitors of prostaglandin synthesis, including PTGR1, GSTP1 and ANXA1, in the uterine fluid of 
pregnant mares. Overall, an overview was created of the proteins playing a role at the embryo-maternal interface 
in the horse. This study provides a solid foundation for further targeted studies of proteins potentially involved in 
embryo-maternal interactions, maternal recognition of pregnancy and pregnancy loss in the horse.
Methods
Sampling. All animal handlings were approved by the Ethical Committee of the Faculty of Veterinary 
Medicine (EC2013/118) of Ghent University. All methods were performed in accordance with the relevant guide-
lines and regulations. A switch back design was followed with 5 mares undergoing two different types of cycles: a 
pregnant cycle (P) and a cyclic control cycle (C). In this way, the samples were paired using the same mare as its 
own control for pregnancy and the experimental unit was the mare. The order of P and C cycles was randomly 
altered for the different mares. No resting cycles were included. During the breeding season, five reproductively 
sound Warmblood mares between 4 and 13 years old were monitored by transrectal ultrasound. Reproductive 
soundness was confirmed by negative cytology and bacteriology. Mares displaying uterine oedema and a follicle 
exceeding 35 mm received 1500 IU hCG intravenously and were either inseminated the next day with fresh semen 
of the same stallion (P) or left unbred (C). Ovulation was evaluated twice daily by ultrasound. In both groups, 
sampling was performed 13 days after detection of ovulation. To recover undiluted uterine fluid in order to avoid 
negative effects of excessive Ringer’s salts on MS59, intra-uterine application of a tampon (OB Mini; Johnson & 
Johnson, Beerse, Belgium) was performed based upon the method described by Wolf et al.33. A double gloved 
technique was used to avoid vaginal contamination. The tampon was left in the uterus during 10 minutes and 
upon removal it was placed in a Falcon tube at 4 °C until further processing. Subsequently, the mare’s uterus was 
flushed with sterile Ringer’s solution by means of a modified endotracheal tube to recover the embryo (P).
To process the uterine fluid, 1 mL of sterile water (B60, Biosolve, Valkenswaard, The Netherlands) was infused 
on top of the tampon and the tampon was attached in the upper part of the Falcon tube by fixing the cord with 
the cap. Subsequently, the Falcon tube was centrifuged for 20 minutes at 1000 × g at 4 °C. The supernatant was 
Figure 4. Involvement of proteins found in the yolk sac fluid and the uterine fluid of pregnant mares in GO 
terms and pathways representing embryo-maternal interaction. All GO terms and pathways that include 
‘embryo’, ‘maternal’ or ‘uterus’ in their description were selected, together with all identified proteins in either 
the yolk sac or uterine fluid of pregnant horses belonging to these GO terms or pathways. These GO terms, 
pathways and proteins were then visualized using Cytoscape 3.3.0. Proteins found only in the uterine fluid 
are represented as red circles, proteins found only in the yolk sac as yellow circles and proteins found in both 
as purple circles. Proteins significantly (FDR corrected p-value < 0.05) up- or downregulated in the uterine 
fluid of pregnant mares are respectively larger and smaller circles (size not scaled with magnitude of up- or 
downregulation). GO terms and pathways are represented as a blue ‘V’, with lines indicating whether a GO term 
or pathway is associated with a protein.
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collected and stored in a Protein LoBind Eppendorf tube (Eppendorf AG, Hamburg, Germany) at −80 °C. 
Meanwhile, the embryo was isolated in a petri dish and the yolk sac fluid was collected by aspiration with a 21 G 
needle and stored in a Protein LoBind Eppendorf at −80 °C.
A total of 15 samples were collected, consisting of uterine fluid (UF) (n = 10) from five biological replicates 
coinciding with the five mares (1–5) for the P and C treatment cycles, as well as yolk sac fluid (YS) (n = 5) from 
the P cycles.
Sample preparation for mass spectrometry analysis. After thawing, protein concentration in each 
sample was determined using the Coomassie (Bradford) Protein Assay Kit (Thermo Fisher Scientific, San José, 
CA, USA) according to the manufacturer’s instructions. Further processing was performed for 10 µg protein of 
each uterine fluid sample and for 500 ng protein of the yolk sac samples. Samples were dissolved in 20 μL 0.5 M 
triethylammonium bicarbonate (TEABC; Sigma-Aldrich, St. Louis, MO, USA). Two µl of reducing agent (10 µM 
DTT; Invitrogen, Merelbeke, Belgium) were added followed by incubation for 1 h at 60 °C. Subsequently, 1 µl of 
alkylizing agent (200 mM methyl methanethiosulfonate (MMTS) in isopropanol; Sigma-Aldrich, St. Louis, MO, 
USA) was added and samples were incubated for 10 min at room temperature. Digestion was performed over-
night at 37 °C with trypsin lys C (1:20, trypsin:protein w/w, Promega, Leiden, The Netherlands) in TEABC buffer 
with 1 mM CACL(2) and 5% acetonitrile (Biosolve, Valkenswaard, The Netherlands). Samples were vacuum-dried 
and stored at −20 °C until analysis.
Data acquisition by HDMSE analysis. The peptides were separated using a nanoscale UPLC system 
(nanoAcquityUPLC, Waters, Milford, USA) coupled to a Synapt G2-Si mass spectrometer (Waters). Peptides 
were first trapped in 0.1% formic acid on a 180 µm × 20 mm C18 Trap column. Separation was performed on a 
HSS C18 1.8 m, 100 m × 250 mm analytical column at a flow rate of 300 nL/min and a temperature of 45 °C. As 
mobile phase A a 0.1% formic acid with 4% DMSO in water solution was used and 80% ACN containing 0.1% 
formic acid constituted mobile phase B. Peptides were separated for 60 min at 1–40% solvent B and for 1 min 
Figure 5. Involvement of proteins found in the yolk sac fluid and the uterine fluid of pregnant mares in GO 
terms and pathways representing embryo-maternal interaction. All GO terms and pathways that include 
‘cytokine’ or ‘growth factor’ in their description were selected, together with all identified proteins in either the 
yolk sac or uterine fluid belonging to these GO terms or pathways. These GO terms, pathways and proteins 
were then visualized using Cytoscape 3.3.0. Proteins found only in the uterine fluid are represented as red 
circles, proteins found only in the yolk sac as yellow circles and proteins found in both as purple circles. Proteins 
significantly (FDR corrected p-value < 0.05) up- or downregulated in the uterine fluid of pregnant mares are 
respectively larger and smaller circles (size not scaled with magnitude of up- or downregulation). GO terms and 
pathways are represented as a blue ‘V’, with lines indicating whether a GO term or pathway is associated with a 
protein.
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40–85% solvent B. Seven minutes of rinsing (85% solvent B) re-equilibrated the column to the initial conditions. 
Eluted peptides were analysed in positive mode ESI-MS using High Definition MSE (HDMSE) with a collision 
energy look up table as described in22. The spectral acquisition time of low and elevated energy scans was 0.6 s 
over an m/z range of 50–2000. [Glu1]-Fibrinopeptide B was used for post-acquisition lock mass correction. All 
Figure 6. Comparison of proteins detected in the uterine fluid (UF) and the yolk sac (YS) with the proteins 
reported by Swegen et al.34. Figure 6A shows the number of proteins which were found in the blastocoel fluid 
by Swegen et al.34 and the YS in our study and Fig. 6B illustrates the proteins those to be secreted in embryo-
conditioned medium at 24 h and 48 h by Swegen et al.34 and in the UF in our study. Numbers are based on the 
reported gene symbols.
Figure 7. Inhibitors of prostaglandin synthesis in uterine fluid of pregnant mares. Eicosanoid pathway, adapted 
from Wikipedia. Proteins found to be upregulated in the uterine fluid of pregnant mares are marked in red.
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UF samples were analysed in the same run; three technical replicates (R1–R3) were run for each sample and four 
quality controls (QC) were included in which all samples were pooled.
Identification and quantification of peptides and proteins. All data were processed in Progenesis 
QIP (Progenesis QIP 2.0, Nonlinear Dynamics, Waters), including normalization and quality control. A data-
base with UniProt IDs was created by conversion of Ensembl gene identifiers for Equus caballus (n = 22295) 
to Uniprot IDs using http://www.uniprot.org/uploadlists/ and including common contaminants (http://www.
thegpm.org/crap/). As only secreted proteins are expected to be found, it can be argued that this database should 
be limited to only these secreted proteins. However, there is much debate on the accuracy of FDR calculations 
with such limited databases60–62 and as such a cautious approach was taken in which all proteins were assessed. 
Using Progenesis QIP, peptides were identified against this database with a FDR of 4%63 and allowing maximum 
one miscleavage. Protein quantification was based on the Hi-3 method64, which uses the average of the three most 
intense peptides of each protein for its quantification. Resulting normalized abundances for each protein, as well 
as unique peptide counts were further used for analysis of differential expression.
Analysis of differential expression. Analysis of differential expression was performed for the UF sam-
ples. Only normalized abundancies of proteins with at least two unique peptides (n = 707) were included in the 
analysis. Pairwise comparisons of differential expression were made for P versus C with the individual horses as a 
blocking factor, using R Bioconductor limma package65 and a FDR of 0.05.
Gene Ontology enrichment and pathway analysis. Gene Ontology (GO) terms (molecular functions, 
biological processes and cellular locations) were downloaded for each protein with the PANTHER Classification 
System66. For the pair-wise comparison of P and C, a statistical overrepresentation test against all quantified pro-
teins was performed for all significantly up- and downregulated (FDR < 0.05) proteins. These tests were done for 
all primary GO classes: molecular functions, biological processes and cellular components. Pathways were ana-
lysed with Bioconductor’s67 GAGE package68. LogFC values of all quantified proteins were used as input against 
Equus caballus background reference pathways from KEGG.
Proteins involved in the embryo-maternal interaction were visualized using Cytoscape 3.3.0. To visualize 
embryo-maternal signalling, all GO terms and pathways that include ‘cytokine’ or ‘growth factor’ in their descrip-
tion were selected, together with all identified proteins in either the yolk sac or uterine fluid belonging to these 
GO terms or pathways. The connection between these GO terms, pathways and proteins was then visualized 
using Cytoscape 3.3.0. The same methodology was used to create a network based on GO terms and pathways 
including ‘embryo’, ‘maternal’ or ‘uterus’ in their description.
Data availability. All data are available in the Supplementary files.
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